HeartSciences (HSCS) Free Cash Flow (2021 - 2026)

HeartSciences has reported Free Cash Flow for 6 years, with the latest figure at -$1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 10.31% year-over-year to -$1.5 million; the trailing twelve-month figure through Jan 2026 stood at -$7.3 million (up 1.57% YoY), and the FY2025 full-year result was -$7.4 million, down 20.89% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$1.5 million, up from -$2.3 million in the prior quarter.
• The five-year high for Free Cash Flow was -$966278.0 in Q1 2022, with the low at -$2.3 million in Q4 2025.
• Historically, Free Cash Flow has averaged -$1.6 million across 5 years, with a median of -$1.6 million in 2025.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 153.52% — and 2025, when it climbed 23.21%.
• HeartSciences' Free Cash Flow stood at -$1.1 million in 2022, then rose by 8.33% to -$990139.0 in 2023, then plunged by 120.53% to -$2.2 million in 2024, then retreated by 6.9% to -$2.3 million in 2025, then surged by 37.75% to -$1.5 million in 2026.
• The last three Free Cash Flow figures came in at -$1.5 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.